How Analysts Now View NVIDIA After Earnings

Photo of Chris Lange
By Chris Lange Updated Published
How Analysts Now View NVIDIA After Earnings

© Thinkstock

NVIDIA Corp. (NASDAQ: NVDA) reported its fourth-quarter earnings this past week and had a very positive reaction from investors while analysts hiked up their price targets. As a side note, this was a record quarter for NVIDIA, which made these earnings that much better.

The company had $0.52 in earnings per share (EPS) on $1.40 billion in revenue, which compared to Thomson Reuters consensus estimates of $0.32 in EPS on revenue of $1.31 billion. In the same period of the previous year, it posted EPS of $0.35 and $1.25 billion in revenue.

In terms of guidance for the first quarter, NVIDIA expects to have revenue of $1.26 billion and a gross margin of 57.5%. Consensus estimates call for $0.28 in EPS on $1.23 billion in revenue for the quarter.

Co-founder and CEO Jen-Hsun Huang commented on these record earnings:

We had another record quarter, capping a record year. Our strategy is to create specialized accelerated computing platforms for large growth markets that demand the 10x boost in performance we offer. Each platform leverages our focused investment in building the world’s most advanced GPU technology.

[recirclink id=315852]
After earnings a few analysts weighed in on the stock:

  • Canaccord Genuity has a Buy rating and raised its price target to $36 from $35.
  • Deutsche Bank has a Hold rating and raised the price target from $25 to $26.
  • Jefferies has a Buy rating and raised its price target to $40 from $38.
  • JP Morgan has a Neutral rating and raised its price target to $33 from $31.
  • Susquehanna has a Neutral rating and raised the price target from $25 to $26.
  • Wedbush has an Outperform rating and raised its price target to $34 from $30.

Shares of NVIDIA ended last week at $30.44, with a consensus analyst price target of $32.04 and a 52-week trading range of $19.09 to $33.94.

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Continue Reading

Top Gaining Stocks

SMCI Vol: 128,836,317
ON Vol: 12,044,310
GLW Vol: 18,574,393
MU Vol: 53,140,821
ABBV Vol: 9,912,803

Top Losing Stocks

CTRA Vol: 73,319,495
MRNA Vol: 8,363,487
PLTR Vol: 56,918,231
VRSN Vol: 1,691,263
CMG Vol: 18,457,730